Transgene Biotek

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue0.060.000.000.000.10
Expenses1.441.771.381.470.25
EBITDA-1.38-1.77-1.38-1.47-0.15
EBIT-2.62-3.01-2.62-2.71-0.17
Profit Before Tax-1.39-1.77-1.38-1.47-0.14
Net Profit-1.39-1.77-1.38-1.47-0.14
Financial Ratios
Operating Profit Margin-2,317%NA%NA%NA%-150.00%
Net Profit Margin-2,317%NA%NA%NA%-140.00%
Earning Per Share (Diluted)-0.18-0.23-0.18-0.19-0.02
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ